Literature DB >> 33462204

Quantifying neurotransmitter secretion at single-vesicle resolution using high-density complementary metal-oxide-semiconductor electrode array.

Kevin A White1, Brian N Kim2,3.   

Abstract

Neuronal exocytosis facilitates the propagation of information through the nervous system pertaining to bodily function, memory, and emotions. Using amperometry, the sub-millisecond dynamics of exocytosis can be monitored and the modulation of exocytosis due to drug treatment or neurodegenerative diseases can be studied. Traditional single-cell amperometry is a powerful technique for studying the molecular mechanisms of exocytosis, but it is both costly and labor-intensive to accumulate statistically significant data. To surmount these limitations, we have developed a silicon-based electrode array with 1024 on-chip electrodes that measures oxidative signal in 0.1 millisecond intervals. Using the developed device, we are able to capture the modulation of exocytosis due to Parkinson's disease treatment (L-Dopa), with statistical significance, within 30 total minutes of recording. The validation study proves our device's capability to accelerate the study of many pharmaceutical treatments for various neurodegenerative disorders that affect neurotransmitter secretion to a matter of minutes.

Entities:  

Year:  2021        PMID: 33462204     DOI: 10.1038/s41467-020-20267-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  37 in total

1.  High calcium concentrations shift the mode of exocytosis to the kiss-and-run mechanism.

Authors:  E Alés; L Tabares; J M Poyato; V Valero; M Lindau; G Alvarez de Toledo
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

Review 2.  Analysis of exocytotic events recorded by amperometry.

Authors:  Eugene V Mosharov; David Sulzer
Journal:  Nat Methods       Date:  2005-09       Impact factor: 28.547

3.  The role of the C terminus of the SNARE protein SNAP-25 in fusion pore opening and a model for fusion pore mechanics.

Authors:  Qinghua Fang; Khajak Berberian; Liang-Wei Gong; Ismail Hafez; Jakob B Sørensen; Manfred Lindau
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

4.  Only a Fraction of Quantal Content is Released During Exocytosis as Revealed by Electrochemical Cytometry of Secretory Vesicles.

Authors:  Donna M Omiatek; Yan Dong; Michael L Heien; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

5.  Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.

Authors:  Kristin E Larsen; Yvonne Schmitz; Matthew D Troyer; Eugene Mosharov; Paula Dietrich; Abrar Z Quazi; Magali Savalle; Venu Nemani; Farrukh A Chaudhry; Robert H Edwards; Leonidas Stefanis; David Sulzer
Journal:  J Neurosci       Date:  2006-11-15       Impact factor: 6.167

6.  A single amino acid near the C terminus of the synaptosomeassociated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells.

Authors:  M Criado; A Gil; S Viniegra; L M Gutiérrez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Amperometric measurements of catecholamine release from single vesicles in MN9D cells.

Authors:  Yan Dong; Michael L Heien; Marc M Maxson; Andrew G Ewing
Journal:  J Neurochem       Date:  2008-12       Impact factor: 5.372

8.  Dopamine neurons release transmitter via a flickering fusion pore.

Authors:  Roland G W Staal; Eugene V Mosharov; David Sulzer
Journal:  Nat Neurosci       Date:  2004-02-29       Impact factor: 24.884

9.  L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro.

Authors:  E Pothos; M Desmond; D Sulzer
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

10.  Actin controls the vesicular fraction of dopamine released during extended kiss and run exocytosis.

Authors:  Raphaël Trouillon; Andrew G Ewing
Journal:  ACS Chem Biol       Date:  2014-01-21       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.